- Home
- NXRT vs CRMD Comparison
NXRT vs CRMD Comparison
Compare NXRT & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXRT
- CRMD
- Stock Information
- Founded
- NXRT 2014
- CRMD 2006
- Country
- NXRT United States
- CRMD United States
- Employees
- NXRT 2
- CRMD N/A
- Industry
- NXRT Real Estate Investment Trusts
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- NXRT Real Estate
- CRMD Health Care
- Exchange
- NXRT Nasdaq
- CRMD Nasdaq
- Market Cap
- NXRT 802.0M
- CRMD 865.2M
- IPO Year
- NXRT N/A
- CRMD 2010
- Fundamental
- Price
- NXRT $31.16
- CRMD $11.56
- Analyst Decision
- NXRT Hold
- CRMD Strong Buy
- Analyst Count
- NXRT 5
- CRMD 8
- Target Price
- NXRT $37.33
- CRMD $17.57
- AVG Volume (30 Days)
- NXRT 171.8K
- CRMD 2.9M
- Earning Date
- NXRT 10-28-2025
- CRMD 10-29-2025
- Dividend Yield
- NXRT 6.55%
- CRMD N/A
- EPS Growth
- NXRT N/A
- CRMD N/A
- EPS
- NXRT N/A
- CRMD 0.79
- Revenue
- NXRT $254,446,000.00
- CRMD $121,484,498.00
- Revenue This Year
- NXRT N/A
- CRMD $446.49
- Revenue Next Year
- NXRT $3.72
- CRMD $59.96
- P/E Ratio
- NXRT N/A
- CRMD $14.61
- Revenue Growth
- NXRT N/A
- CRMD 14970.29
- 52 Week Low
- NXRT $29.98
- CRMD $5.60
- 52 Week High
- NXRT $48.31
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- NXRT 38.01
- CRMD 46.14
- Support Level
- NXRT $31.49
- CRMD $10.95
- Resistance Level
- NXRT $32.22
- CRMD $12.29
- Average True Range (ATR)
- NXRT 0.66
- CRMD 0.53
- MACD
- NXRT -0.14
- CRMD -0.00
- Stochastic Oscillator
- NXRT 7.59
- CRMD 45.52
About NXRT NexPoint Residential Trust Inc.
NexPoint Residential Trust Inc is a real estate investment trust company. Its objectives are to maximize the cash flow and value of properties owned, acquire properties with cash flow growth potential, provide quarterly cash distributions, and achieve long-term capital appreciation for stockholders. The company seeks to achieve these objectives through targeted management and a capex value-add program. It focuses on acquiring multifamily properties in markets with attractive job growth and household formation fundamentals predominantly in the Southeastern and Southwestern United States. The company generates revenue from the rental of multifamily properties.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.